Mrs Valerie Jill Robertson, CCC-SLP | |
2311 Cedar Bnd, Anderson, IN 46011-1082 | |
(765) 621-1593 | |
Not Available |
Full Name | Mrs Valerie Jill Robertson |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 2311 Cedar Bnd, Anderson, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003059023 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 22003210A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Valerie Jill Robertson, CCC-SLP 2311 Cedar Bnd, Anderson, IN 46011-1082 Ph: (765) 621-1593 | Mrs Valerie Jill Robertson, CCC-SLP 2311 Cedar Bnd, Anderson, IN 46011-1082 Ph: (765) 621-1593 |
News Archive
A study of gene activity in the brain's hippocampus, led by UT Southwestern researchers, has identified marked differences between the region's anterior and posterior portions. The findings, published today in Neuron, could shed light on a variety of brain disorders that involve the hippocampus and may eventually help lead to new, targeted treatments.
Kessler Foundation received a $250,000 stroke research grant from the Wallerstein Foundation for Geriatric Life Improvement. Anna Barrett, MD, director of Stroke Rehabilitation Research at Kessler Foundation, will apply the funds to finding better ways to treat hidden disabilities that often complicate recovery after stroke.
The genetic alphabet contains four letters. Although our cells can readily decipher our genetic molecules, it isn't so easy for us to read a DNA sequence in the laboratory. Scientists require complex, highly sophisticated analytical techniques to crack individual DNA codes.
AstraZeneca today announced top-line results of OSKIRA-1, a Phase 3 study to assess the efficacy and safety of fostamatinib, the first oral spleen tyrosine kinase inhibitor in development for rheumatoid arthritis.
A subpopulation of the immune cells targeted by HIV may play an important role in controlling viral loads after initial infection, potentially helping to determine how quickly infection will progress. In the February 29 issue of Science Translational Medicine, a team of researchers from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard describe finding a population of HIV-specific CD4 T cells - cells traditionally thought to direct and support activities of other immune cells - that can directly kill HIV-infected cells.
› Verified 6 days ago
Michelle Rose, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Main St Ste 204, Anderson, IN 46016 Phone: 765-644-0500 Fax: 765-644-0510 | |
Mrs. Lindsey Ann-marie Zurawski, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1345 N Madison Ave, Anderson, IN 46011 Phone: 765-644-2888 Fax: 765-683-4372 | |
Stephanie Ketring, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Main St Ste 204, Anderson, IN 46016 Phone: 765-644-0500 | |
Ms. Gina Pease Russel, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4610 Madison Ave, Anderson, IN 46013 Phone: 765-641-2037 Fax: 765-641-2041 | |
Mrs. Susan Michelle Lee, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1827 N Madison Ave Ste B, Anderson, IN 46011 Phone: 765-313-7570 Fax: 844-364-1385 | |
Lora Repp, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5325 Main St, Anderson, IN 46013 Phone: 765-642-0201 |